Medicaldevicehub

NCT ID:	NCT00002320
NLM Download Date Description:	N/A
Study First Submitted Date:	1999-11-02
Last Update Submitted Date:	2005-12-08
Last Update Submitted Date:	2005-12-08
Result First Submitted Date:	N/A
Disposition First Submitted Date:	N/A
Start Month Year:	N/A
Start Date:	N/A
Start Date Type:	N/A
Verification Month Year:	May 1994
Verification Date:	1994-05-31
Completion Month Year:	N/A
Completion Date:	N/A
Completion Date Type:	N/A
Primary Completion Month Year:	N/A
Primary Completion Date:	N/A
Primary Completion Date Type:	N/A
Study first Submitted QC Date:	2001-08-30
Study first posted Date:	2001-08-31
Result first Submitted QC Date:	N/A
Result First Posted Date:	N/A
Disposition First Submitted QC Date:	N/A
Disposition First Posted Date:	N/A
Last Updated Submitted QC Date:	2005-12-08
Last Updated Posted Date:	2005-12-12
Target Duration:	N/A
Study Type:	Interventional
Acronym:	N/A
Baseline Population:	N/A
Brief Title:	A Comparison of Lamivudine and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Not Used Zidovudine in the Past
Official Title:	A Randomized, Double-Blind Multicenter Trial to Compare the Safety and Efficacy of Lamivudine (3TC; GR109714X) Monotherapy Versus Zidovudine (AZT) Monotherapy Versus 3TC Administered With AZT in the Treatment of HIV-1 Infected Patients Who Are AZT Naive (< 4 Weeks) With CD4 Cell Counts of 200-500 Cells/mm3
Overall Status:	Completed
Last Known Status:	N/A
Phase:	Phase 3
Enrollment:	320
Enrollment Type:	N/A
Source:	NIH AIDS Clinical Trials Information Service
Limitation and Caveats:	N/A
Number of Arms:	N/A
Number of Groups:	N/A
Why Stopped:	N/A
Has Expanded Access:	N/A
Expanded Access Type Individual:	N/A
Expanded Access Type Intermediate:	N/A
Expanded Access Type Treatment:	N/A
Has DMC:	N/A
Is it FDA Regulated Drug:	N/A
Is it FDA Regulated Device:	N/A
Is it Unapproved Device:	N/A
Is PPSD:	N/A
Is US Export:	N/A
Is Biospec Retention:	N/A
Biospec Description:	N/A
Plan to Share IPD:	N/A
Plan to Share IPD Description:	N/A
IPD Time Frame:	N/A
IPD Access Criteria:	N/A
IPD URL:	N/A

NCT ID:

NCT00002320

NLM Download Date Description:

N/A

Study First Submitted Date:

1999-11-02

Last Update Submitted Date:

2005-12-08

Last Update Submitted Date:

2005-12-08

Result First Submitted Date:

N/A

Disposition First Submitted Date:

N/A

Start Month Year:

N/A

Start Date:

N/A

Start Date Type:

N/A

Verification Month Year:

May 1994

Verification Date:

1994-05-31

Completion Month Year:

N/A

Completion Date:

N/A

Completion Date Type:

N/A

Primary Completion Month Year:

N/A

Primary Completion Date:

N/A

Primary Completion Date Type:

N/A

Study first Submitted QC Date:

2001-08-30

Study first posted Date:

2001-08-31

Result first Submitted QC Date:

N/A

Result First Posted Date:

N/A

Disposition First Submitted QC Date:

N/A

Disposition First Posted Date:

N/A

Last Updated Submitted QC Date:

2005-12-08

Last Updated Posted Date:

2005-12-12

Target Duration:

N/A

Study Type:

Interventional

Acronym:

N/A

Baseline Population:

N/A

Brief Title:

A Comparison of Lamivudine and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Not Used Zidovudine in the Past

Official Title:

A Randomized, Double-Blind Multicenter Trial to Compare the Safety and Efficacy of Lamivudine (3TC; GR109714X) Monotherapy Versus Zidovudine (AZT) Monotherapy Versus 3TC Administered With AZT in the Treatment of HIV-1 Infected Patients Who Are AZT Naive (< 4 Weeks) With CD4 Cell Counts of 200-500 Cells/mm3

Overall Status:

Completed

Last Known Status:

N/A

Phase:

Phase 3

Enrollment:

320

Enrollment Type:

N/A

Source:

NIH AIDS Clinical Trials Information Service

Limitation and Caveats:

N/A

Number of Arms:

N/A

Number of Groups:

N/A

Why Stopped:

N/A

Has Expanded Access:

N/A

Expanded Access Type Individual:

N/A

Expanded Access Type Intermediate:

N/A

Expanded Access Type Treatment:

N/A

Has DMC:

N/A

Is it FDA Regulated Drug:

N/A

Is it FDA Regulated Device:

N/A

Is it Unapproved Device:

N/A

Is PPSD:

N/A

Is US Export:

N/A

Is Biospec Retention:

N/A

Biospec Description:

N/A

Plan to Share IPD:

N/A

Plan to Share IPD Description:

N/A

IPD Time Frame:

N/A

IPD Access Criteria:

N/A

IPD URL:

N/A

Detailed Result for NCT00002320